ALA group:Intravenous infusion of lipoic acid at a dose of 600mg once a day for 7 consecutive days

2 trials

Sponsors

Weifang People's Hospital, Suzhou Ninth People's Hospital

Conditions

Sepsis-Associated Intestinal Injuryacute respiratory distress syndrome (ARDS)

Phase 4

Lipoic acid as adjunctive therapy for sepsis-related moderate-to-severe ARDS: a single-center, randomized, double-blind, placebo-controlled phase II trial

Active, not recruitingChiCTR2500115388

Weifang People's Hospitalacute respiratory distress syndrome (ARDS)

Start: 2026-01-01Updated: 2026-01-05

Lipoic acid adjuvant therapy for sepsis-associated acute intestinal dysfunction: a single-center, randomized, single-blind, placebo-controlled phase II clinical trial

Active, not recruitingChiCTR2600125019

Suzhou Ninth People's HospitalSepsis-Associated Intestinal Injury

Start: 2026-05-22Updated: 2026-05-25